Loading...

Albert Chang, MD, PhD

TitleAsst. Professor in Residence
SchoolUCSF School of Medicine
DepartmentRadiation Oncology
Address1600 Divisadero
San Francisco CA 94115
Phone415-353-7177
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Boston UniversityM.D.2007School of Medicine

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kunogi H, Cunha JAM, Chang A, Gadzinski AJ, Shinohara K, Hsu IC. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate. Brachytherapy. 2017 Aug 28. PMID: 28869143.
      View in: PubMed
    2. Paulsson AK, Yom SS, Anwar M, Pinnaduwage D, Sudhyadhom A, Gottschalk AR, Chang A, Descovich M. Respiration-Induced Intraorgan Deformation of the Liver. Technol Cancer Res Treat. 2017 Jan 01; 1533034616687193. PMID: 28071340.
      View in: PubMed
    3. Choi JY, Yang J, Noworolski SM, Behr S, Chang A, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y, et al. 18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 2017 Feb; 282(2):429-436. PMID: 27513849.
      View in: PubMed
    4. Zhang L, Johnson J, Gottschalk AR, Chang A, Hsu IC, Roach M, Seymour ZA. Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2017 Mar - Apr; 7(2):e109-e116. PMID: 28274401.
      View in: PubMed
    5. Baumann BC, Bosch WR, Bahl A, Birtle AJ, Breau RH, Challapalli A, Chang A, Choudhury A, Daneshmand S, El-Gayed A, Feldman A, Finkelstein SE, Guzzo TJ, Hilman S, Jani A, Malkowicz SB, Mantz CA, Master V, Mitra AV, Murthy V, Porten SP, Richaud PM, Sargos P, Efstathiou JA, Eapen LJ, Christodouleas JP. Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy. Int J Radiat Oncol Biol Phys. 2016 Sep 01; 96(1):78-86. PMID: 27511849.
      View in: PubMed
    6. Raleigh DR, Chang A, Tomlin B, Cunha JA, Braunstein SE, Shinohara K, Gottschalk AR, Roach M, Hsu IC. Patient- and treatment-specific predictors of genitourinary function after high-dose-rate monotherapy for favorable prostate cancer. Brachytherapy. 2015 Nov-Dec; 14(6):795-800. PMID: 26198421.
      View in: PubMed
    7. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang A, Chan JM, Simko JP, Carroll PR. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. PMID: 25983194.
      View in: PubMed
    8. Seymour ZA, Chang A, Zhang L, Kirby N, Descovich M, Roach M, Hsu IC, Gottschalk AR. Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer. Pract Radiat Oncol. 2015 Sep-Oct; 5(5):e465-72. PMID: 25795252.
      View in: PubMed
    9. Raleigh DR, Hsu IC, Braunstein S, Chang A, Simko JP, Roach M. Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy. Brachytherapy. 2015 Mar-Apr; 14(2):185-8. PMID: 25533416.
      View in: PubMed
    10. Chang A. Editorial comment. Urology. 2014 Dec; 84(6):1387-8. PMID: 25475226.
      View in: PubMed
    11. Nedrow JR, White AG, Modi J, Nguyen K, Chang A, Anderson CJ. Positron Emission Tomographic Imaging of Copper 64- and Gallium 68-Labeled Chelator Conjugates of the Somatostatin Agonist Tyr3-Octreotate. Mol Imaging. 2014 Sep 01; 13(7):7290201400020. PMID: 28650295.
      View in: PubMed
    12. Chang A, Autio KA, Roach M, Scher HI. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014 Jun; 11(6):308-23. PMID: 24840073; PMCID: PMC4508854.
    13. Anwar M, Weinberg V, Chang A, Hsu IC, Roach M, Gottschalk A. Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir. Radiat Oncol. 2014 Feb 02; 9:42. PMID: 24484652; PMCID: PMC3923240.
    14. Beaino W, Guo Y, Chang A, Anderson CJ. Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy. J Biol Inorg Chem. 2014 Mar; 19(3):427-38. PMID: 24445997; PMCID: PMC3951176.
    15. Nedrow JR, White AG, Modi J, Nguyen K, Chang A, Anderson CJ. Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate. Mol Imaging. 2014; 13. PMID: 25060207; PMCID: PMC4265553.
    16. Chang A, Sohn R, Lu ZH, Arbeit JM, Lapi SE. Detection of rapalog-mediated therapeutic response in renal cancer xenografts using 64Cu-bevacizumab immunoPET. PLoS One. 2013; 8(3):e58949. PMID: 23516584; PMCID: PMC3597567.
    17. Chen CP, Weinberg V, Shinohara K, Roach M, Nash M, Gottschalk A, Chang A, Hsu IC. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013 Jun 01; 86(2):324-9. PMID: 23474112.
      View in: PubMed
    18. Garsa AA, Chang A, Dewees T, Spencer CR, Adkins DR, Dehdashti F, Gay HA, Thorstad WL. Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma. J Radiat Oncol. 2013 Mar; 2(1):27-34. PMID: 24563726.
      View in: PubMed
    19. Chang A, Roach M. Cautious optimism for extreme dose escalation in prostate cancer. Eur Urol. 2013 Dec; 64(6):939-40. PMID: 23506832.
      View in: PubMed
    20. Chang A, De Silva RA, Lapi SE. Development and characterization of 89Zr-labeled panitumumab for immuno-positron emission tomographic imaging of the epidermal growth factor receptor. Mol Imaging. 2013 Jan-Feb; 12(1):17-27. PMID: 23348788; PMCID: PMC4329987.
    21. Gay HA, Jin JY, Chang A, Ten Haken RK. Utility of normal tissue-to-tumor a/ß ratio when evaluating isodoses of isoeffective radiation therapy treatment plans. Int J Radiat Oncol Biol Phys. 2013 Jan 01; 85(1):e81-7. PMID: 23141886.
      View in: PubMed
    22. Chang A, Roach M. Radium-223: down to the bone, and less is more. Oncology (Williston Park). 2012 Apr; 26(4):342, 344. PMID: 22655526.
      View in: PubMed
    23. Chang A, Desilva R, Jain S, Lears K, Rogers B, Lapi S. 89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors. Pharmaceuticals (Basel). 2012 Jan 05; 5(1):79-93. PMID: 24288044; PMCID: PMC3763623.
    24. Chang A, Zhao H, Wahab SH, Moore K, Taylor M, Zoberi I, Powell SN, Klein EE. Video surface image guidance for external beam partial breast irradiation. Pract Radiat Oncol. 2012 Apr-Jun; 2(2):97-105. PMID: 24674085.
      View in: PubMed
    25. Chang A, Dehdashti F, Bradley JD. The role of positron emission tomography for non-small cell lung cancer. Pract Radiat Oncol. 2011 Oct-Dec; 1(4):282-8. PMID: 24674007.
      View in: PubMed
    26. Chang A, Richardson S, Grigsby PW, Schwarz JK. Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):263-9. PMID: 21167656.
      View in: PubMed
    27. Chang A, Bradley JD. Clinical perspectives on dose escalation for non-small-cell lung cancer. Clin Lung Cancer. 2010 Sep 01; 11(5):299-302. PMID: 20837454.
      View in: PubMed
    28. Chang A, Song DH, Wolfe MM. Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation. J Biol Chem. 2006 May 26; 281(21):14700-10. PMID: 16574647.
      View in: PubMed
    29. Yao M, Zhou W, Sangha S, Albert A, Chang A, Liu TC, Wolfe MM. Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer. Clin Cancer Res. 2005 Feb 15; 11(4):1618-28. PMID: 15746067.
      View in: PubMed
    30. Moore TC, Jepeal LI, Boylan MO, Singh SK, Boyd N, Beer DG, Chang A, Wolfe MM. Gastrin stimulates receptor-mediated proliferation of human esophageal adenocarcinoma cells. Regul Pept. 2004 Aug 15; 120(1-3):195-203. PMID: 15177938.
      View in: PubMed
    31. Chang A, Dixit V, Saab S. Fulminant Hepatic Failure. Curr Treat Options Gastroenterol. 2003 Dec; 6(6):473-479. PMID: 14585236.
      View in: PubMed
    32. Saab S, Chang A, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl. 2003 Oct; 9(10):1053-61. PMID: 14526400.
      View in: PubMed
    Albert's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP